Welcome to NIPTE
The goal of NIPTE will be to become the pre-eminent interdisciplinary national resource for research and education on science and engineering based understanding of pharmaceutical development and manufacturing. Scientists, researchers and engineers from academia, the FDA and the industry will collaboratively engage in developing state-of-the-art science and technology to enable the pharmaceutical industry to develop products faster, and at a significantly lower cost with less variability and higher predictability of performance.



Workshop on the Strategic Pharmaceutical Technology and Education Roadmap

September 7-8, 2006 at FDA facilities in Rockville , MD
NIPTE members have been working on developing a Strategic Roadmap for Research and Education to address the gaps that exist in today's science and technology for pharmaceutical product development and manufacturing. This strategic roadmap is essential for the allocation of available funds and resources to areas of research and education that we all agree should be the highest priority for the NIPTE members. The goal of this meeting is to present the draft roadmaps and to receive feedback before the strategic plan is finalized. Read More >>>

FDA/URI Joint Conference CDER on CMC: 21st Century Pharmaceutical Manufacturing & Control Strategies - A New Paradigm
October 17-18, 2006 at the Hyatt Regency Reston Center, VA
The U.S. Food and Drug Administration (FDA) and the University of Rhode Island College of Pharmacy (URI) are co-sponsoring a conference on October 17-18, 2006 at the Hyatt Regency Reston Town Center, Reston, VA on the progress the FDA has made on the 21st Century Initiative since the final report. This event will include discussions with the Director of each CMC review Office in CDER and the Director of the Office of Testing and Research. Details of specific efforts to better meet Critical Path Industrialization goals will be provided.
Read More >>>

Road-Mapping for the Future of Pharmaceutical Technology: Critical Research and Education Issues
October 30, 2006 at Henery B. Gonzalez Convention Center in San Antonio , TX
In the FDA’s white paper on the critical path to development of pharmaceutical products, industrialization, or what we call pharmaceutical technology, was highlighted. The document points out that, "the pharmaceutical industry generally has been hesitant to introduce state-of-the-art science into its manufacturing processes, in part due to high in-process inventories, low factory utilization rates, significant product wastage, and compliance problems, driving up costs and decreasing productivity." Read More >>>

ISPE - NIPTE Seminar on Pharmaceutical Technology and Education
November 5–7, 2006 Walt Disney World in Lake Buena Vista , Florida
The ISPE Annual Meeting is your yearly opportunity to get broad exposure to the widest range of hot topics and industry issues in pharmaceutical manufacturing. Take your knowledge to the next level with in-depth sessions and workshops in your chosen field - or expose yourself to a new discipline. By picking and choosing the educational sessions that meet your needs, you'll be able to build a customized learning experience. Read More >>>

Technology Roadmap: Pharmaceutical Product Development & Manufacturing
NIPTE Leadership presents Technology and Education Roadmap for Pharmaceutical Product Development and Manufacturing at the Annual Meeting of the American Institute of Chemical Engineers on November 15, 2006. Read More >>>


Center Highlights

Sen. Roberts Co-Sponsors Bill
We are pleased to report that Sen. Pat Roberts of Kansas has agreed to cosponsor the NIPTE authorization bill, S. 2793, the Pharmaceutical Technology and Education Enhancement Act.

Senate bill would benefit NIPTE

Sen. Richard Lugar, R-Ind., has introduced a bill in the Senate that would give a boost to a multi-university consortium created to develop pharmaceutical products faster, more safely and at a lower cost to consumers.
Read More | View Bill
----------------------------------------------
Workshop on Pharmaceutics Education identifies NIPTE for possible source for curriculum for pharmaceutics.

Please see Pharmacy Today, July 2006, Volume 12, Number 6.
----------------------------------------------
Lilly exec says drug development costs could top $2 billion
The costs of producing a successful new drug could reach $2 billion by 2010 if pharmaceutical firms do not improve the drug development process, says Eli Lilly executive vice president Steven Paul. Several factors are working against the industry, such as soaring research and development costs, fewer drug approvals, the loss of patent protection, safety issues and pricing pressures, he said. Read More >>>
----------------------------------------------
FDA and NIPTE signed a
Memorandum of Agreement

FDA & NIPTE agree to cooperate in:

• Establishment of a multi-partner organization with strong research programs in drug development, pharmaceutical manufacturing and regulatory science.

• Development of science based understanding of pharmaceutical materials and manufacturing processes, where appropriate.

• Development and conduct of educational programs for scientists from FDA and industry.



For webpage enquiries, please contact: nipte@purdue.edu
Some Photos Copyright © 2005 Havione and GlaxoSmithKline